Mark Agulnik
Dr. Agulnik earned his medical degree at McGill University School of Medicine in Montreal, Canada. After graduating, he completed his residency in internal medicine at Dalhousie University in Halifax, Nova Scotia. His fellowship in hematology and oncology was conducted at the University of Illinois at Chicago. He subsequently completed a Clinical Research Fellowship at The University of Toronto’s Princess Margaret Hospital with a focus on Head and Neck Cancer. Currently, Dr. Agulnik serves as Director of the Head and Neck and Sarcoma programs at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He also serves as the Fellowship Program Director for the Department of Hematology and Oncology. Dr. Agulnik is a member of the American Society of Clinical Oncology, as well as the Connective Tissue Oncology Society. His research interests early drug development for both Head and Neck Cancers and Sarcomas. Dr. Agulnik is a panel member on both the National Comprehensive Cancer Network (NCCN) Bone Cancer Panel and Occult Primary Panel. He is a member of the National Cancer Institute Rare Tumors Task Force of the Head and Neck Cancer Steering Committee and an ECOG Head and Neck Cancer Committee Member.